AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33200413 — intervention group
Group type: COMPARATOR
Intervention: Control group (diary-only)
Number of subjects: 139
Study 34419626 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylnaltrexone
Number of subjects: 82
Study 34419626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 32744512 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN therapy
Number of subjects: 222
Study 32744512 — intervention group
Group type: COMPARATOR
Intervention: PEG‐IFN monotherapy
Number of subjects: 222
Study 32744512 — intervention group
Group type: COMPARATOR
Intervention: HBsAg <20,000 IU/ml
Number of subjects: 222
Study 35457704 — intervention group
Group type: EXPERIMENTAL
Intervention: Slackline training (15 min per day for 5 days)
Number of subjects: 28
Study 35457704 — intervention group
Group type: EXPERIMENTAL
Intervention: Slackline training
Number of subjects: 28
Study 33774968 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of diltiazem gel
Number of subjects: 80
Study 33774968 — intervention group
Group type: COMPARATOR
Intervention: Control group (no diltiazem gel)
Number of subjects: 80
Study 32637624 — intervention group
Group type: EXPERIMENTAL
Intervention: Formalizing customary land rights program
Number of subjects: 70000
Study 32637624 — intervention group
Group type: COMPARATOR
Intervention: Control group (villages without the program)
Number of subjects: 70000
Study 34774639 — intervention group
Group type: EXPERIMENTAL
Intervention: Sebelipase alfa
Number of subjects: 66
Study 34774639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 34957157 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong exercise program for 12 weeks
Number of subjects: 125
Study 34957157 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 125
Study 33183576 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin 1000 mg/day for 12 weeks
Number of subjects: 60
Study 33183576 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 60
Study 35546206 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 steps walking exercise
Number of subjects: 300
Study 35546206 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 steps walking exercise
Number of subjects: 300
Study 35546206 — intervention group
Group type: COMPARATOR
Intervention: 0 steps walking exercise
Number of subjects: 300
Study 35546206 — intervention group
Group type: EXPERIMENTAL
Intervention: Intestinal cleansing interval (< 5.12 h)
Number of subjects: 300
Study 33657871 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular intradermal acupuncture (AIA)
Number of subjects: 49
Study 33657871 — intervention group
Group type: COMPARATOR
Intervention: Sham AIA
Number of subjects: 49
Study 32451203 — intervention group
Group type: EXPERIMENTAL
Intervention: Education group (received face-to-face information and an education booklet)
Number of subjects: 0
Study 32451203 — intervention group
Group type: COMPARATOR
Intervention: Control group (received usual care)
Number of subjects: 0
Study 32106792 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate/Vitamin D3 70 mg/5600 IU for 24 weeks (concomitant treatment arm, CTA)
Number of subjects: 29
Study 32106792 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate/Vitamin D3 70 mg/5600 IU starting 24 weeks after study entry (delayed treatment arm, DTA)
Number of subjects: 29
Study 32106792 — intervention group
Group type: COMPARATOR
Intervention: No bone anti-resorptive therapy (standard of care, SOC)
Number of subjects: 29
Study 35220831 — intervention group
Group type: EXPERIMENTAL
Intervention: BD Venflon™ I with Instaflash needle technology
Number of subjects: 1402
Study 35220831 — intervention group
Group type: COMPARATOR
Intervention: BD Venflon™ without Instaflash needle technology
Number of subjects: 1402
Study 32445738 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid CSII regimen
Number of subjects: 31
Study 32445738 — intervention group
Group type: COMPARATOR
Intervention: Usual CSII regimen
Number of subjects: 31
Study 35201671 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonton Obesity Staging System (EOSS) scores in early pregnancy
Number of subjects: 348
Study 35201671 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonton Obesity Staging System (EOSS) scores in late pregnancy
Number of subjects: 348
Study 35201671 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in EOSS scores from early to late pregnancy
Number of subjects: 348
Study 35201671 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in EOSS scores for women moving from stage 0 to stage 2
Number of subjects: 348
Study 35201671 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship between early EOSS and large for gestational age
Number of subjects: 348
Study 33677781 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month weight loss intervention
Number of subjects: 151
Study 33677781 — intervention group
Group type: COMPARATOR
Intervention: usual care group
Number of subjects: 151
Study 36018510 — intervention group
Group type: EXPERIMENTAL
Intervention: RMET (Respiratory Muscle Endurance Training)
Number of subjects: 24
Study 36018510 — intervention group
Group type: COMPARATOR
Intervention: PLA (Placebo)
Number of subjects: 24
Study 33551004 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined chemical, mechanical, and heat cleaning
Number of subjects: 32
Study 33551004 — intervention group
Group type: COMPARATOR
Intervention: Standard cleaning
Number of subjects: 32
Study 34006150 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine tubeless PCNL
Number of subjects: 4
Study 33851442 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention to reduce disordered eating
Number of subjects: 100
Study 33851442 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 100
Study 32017246 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (ATE)
Number of subjects: 68
Study 32017246 — intervention group
Group type: COMPARATOR
Intervention: Adenotonsillotomy (ATT)
Number of subjects: 68
Study 32017246 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients (ATE + ATT)
Number of subjects: 68
Study 35696375 — intervention group
Group type: EXPERIMENTAL
Intervention: E-SEE Steps model (Incredible Years® parent program)
Number of subjects: 29
Study 35696375 — intervention group
Group type: EXPERIMENTAL
Intervention: IY training and supervision for practitioners
Number of subjects: 29
Study 35696375 — intervention group
Group type: EXPERIMENTAL
Intervention: IY Babies book as a standalone universal component
Number of subjects: 29
Study 35696375 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted programs for parents with low mood
Number of subjects: 29
Study 35696375 — intervention group
Group type: EXPERIMENTAL
Intervention: Alignment of PU model with commissioned service contracts
Number of subjects: 29
Study 34971192 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Physical Activity (PA) - 26-week supervised aerobic exercise program at 70-80% heart rate reserve for 50 minutes, 3 times per week
Number of subjects: 23
Study 34971192 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Physical Activity (PA)
Number of subjects: 23
Study 34971192 — intervention group
Group type: COMPARATOR
Intervention: Usual Physical Activity (PA)
Number of subjects: 23
Study 34355408 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele‐P cognitive behavioural intervention (CBT)
Number of subjects: 0
Study 34355408 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33705849 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 142
Study 33705849 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 142
Study 32535917 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicon (Si) at 2 mmol L‐1
Number of subjects: 4
Study 32535917 — intervention group
Group type: COMPARATOR
Intervention: Control (no Si)
Number of subjects: 4
Study 35120306 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-EGFR agent
Number of subjects: 1607
Study 35120306 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 1607
Study 35120306 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 1607
Study 32772460 — intervention group
Group type: EXPERIMENTAL
Intervention: Early arm education on organ donation (mosque-based, religiously tailored education)
Number of subjects: 158
Study 32772460 — intervention group
Group type: COMPARATOR
Intervention: Late arm education on organ donation (control educational workshop)
Number of subjects: 158
Study 35649214 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led telephone-based primary palliative care intervention
Number of subjects: 151
Study 35649214 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 151
Study 34605551 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel lifestyle intervention
Number of subjects: 0
Study 34605551 — intervention group
Group type: COMPARATOR
Intervention: Diabetes Prevention Program
Number of subjects: 0
Study 32183793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behaviour Therapy (DBT) - weekly individual cognitive behavioural therapy sessions and a 2.5 h skills training group session twice per week for 6 months
Number of subjects: 128
Study 32183793 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual - weekly individual therapy sessions of 30-45 min with a psychotherapist or social worker
Number of subjects: 128
Study 32183793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behaviour Therapy (DBT)
Number of subjects: 128
Study 32183793 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 128
Study 35732620 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg/d for 12 weeks
Number of subjects: 100
Study 35732620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32450939 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted CBT-based guided self-help (CACBT-GSH) intervention (eight sessions, one session per week)
Number of subjects: 76
Study 32450939 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 76
Study 33563035 — intervention group
Group type: COMPARATOR
Intervention: Traditional weight loss program
Number of subjects: 94
Study 33563035 — intervention group
Group type: EXPERIMENTAL
Intervention: Program including training in providing support
Number of subjects: 94
Study 33932272 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3) LVAD
Number of subjects: 2200
Study 36228978 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy using methylene blue and IPL (560 to 700 nm, fluence 12 J/cm2)
Number of subjects: 51
Study 36228978 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser (10,600 nm, 1.600 mj energy and 0.6 mm density)
Number of subjects: 51
Study 36228978 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined fractional CO2 laser and photodynamic therapy
Number of subjects: 51
Study 36228978 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 51
Study 34925341 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagal Nerve Stimulation (VNS)
Number of subjects: 7
Study 34436943 — intervention group
Group type: EXPERIMENTAL
Intervention: Written self-disclosure by CWS
Number of subjects: 424
Study 34436943 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother-written disclosure
Number of subjects: 424
Study 34436943 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-written disclosure
Number of subjects: 424
Study 34436943 — intervention group
Group type: COMPARATOR
Intervention: Control group (no written disclosure)
Number of subjects: 424
Study 32478024 — intervention group
Group type: EXPERIMENTAL
Intervention: PCGH (physical conditioning group with an extra-session focus on hypertrophy)
Number of subjects: 48
Study 32478024 — intervention group
Group type: EXPERIMENTAL
Intervention: PCG (physical conditioning group)
Number of subjects: 48
Study 32478024 — intervention group
Group type: COMPARATOR
Intervention: PCGP (physical conditioning group with an extra-session in a shallow pool)
Number of subjects: 48
Study 34281516 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief advice plus behavioural change guidance carried out by community champions
Number of subjects: 1000
Study 34281516 — intervention group
Group type: COMPARATOR
Intervention: Brief advice only
Number of subjects: 1000
Study 34281516 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 1000
Study 32331806 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dose MMR vaccination at 9 months and 2.5 years
Number of subjects: 0
Study 35066508 — intervention group
Group type: EXPERIMENTAL
Intervention: Online 15‐min educational module on obesity, weight bias, stigma, and discrimination
Number of subjects: 3290
Study 35066508 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3290
Study 34018223 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger
Number of subjects: 141
Study 34018223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 35483811 — intervention group
Group type: EXPERIMENTAL
Intervention: Intentional team formation (n = 91)
Number of subjects: 159
Study 35483811 — intervention group
Group type: COMPARATOR
Intervention: Randomized team formation (n = 68)
Number of subjects: 159
Study 33397050 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasonography (POCUS)
Number of subjects: 208
Study 33397050 — intervention group
Group type: COMPARATOR
Intervention: Standard diagnostic strategy (Control)
Number of subjects: 208
Study 35701778 — intervention group
Group type: EXPERIMENTAL
Intervention: Ninjin'yoeito (NYT) 7.5 g/day along with 100 mg/day iron supplementation
Number of subjects: 30
Study 35701778 — intervention group
Group type: COMPARATOR
Intervention: Iron supplementation 100 mg/day
Number of subjects: 30
Study 33118901 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS intervention for nutrition information delivery
Number of subjects: 298
Study 33118901 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal counselling (IPC) intervention
Number of subjects: 298
Study 32467034 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized N-acetyl cysteine (NAC), 2 ml of 10% NAC nebulized every six hours.
Number of subjects: 60
Study 32467034 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving saline nebulization.
Number of subjects: 60
Study 36364858 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-food plant-based diet (PBD)
Number of subjects: 70
Study 36364858 — intervention group
Group type: COMPARATOR
Intervention: Omnivorous diet (Control)
Number of subjects: 70
Study 32827752 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 106
Study 32827752 — intervention group
Group type: COMPARATOR
Intervention: Linagliptin 5 mg
Number of subjects: 106
Study 36415122 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-73763989 (100 mg)
Number of subjects: 18
Study 36415122 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-73763989 (200 mg)
Number of subjects: 18
Study 36415122 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-73763989 (100 mg) and (200 mg)
Number of subjects: 18
Study 35656677 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (5 mg/0.2 mL)
Number of subjects: 10
Study 35656677 — intervention group
Group type: COMPARATOR
Intervention: Control (injectable sterile water)
Number of subjects: 10
Study 35656677 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 10
Study 35656677 — intervention group
Group type: COMPARATOR
Intervention: Denosumab and Control
Number of subjects: 10
Study 36385718 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic counselor-led appointment with a communication booklet
Number of subjects: 22
Study 36385718 — intervention group
Group type: COMPARATOR
Intervention: Current clinical practice (return of genetic result by a genetic counselor and cardiologist)
Number of subjects: 22
Study 35225516 — intervention group
Group type: EXPERIMENTAL
Intervention: Endonucleation chop (EC)
Number of subjects: 100
Study 35225516 — intervention group
Group type: COMPARATOR
Intervention: Conventional crater chop (CC)
Number of subjects: 100
Study 32074341 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional transducers
Number of subjects: 40
Study 32074341 — intervention group
Group type: COMPARATOR
Intervention: Novel transducers
Number of subjects: 40
Study 35227112 — intervention group
Group type: EXPERIMENTAL
Intervention: PA Intervention
Number of subjects: 131
Study 35227112 — intervention group
Group type: COMPARATOR
Intervention: Wellness Control
Number of subjects: 131
Study 35675051 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1% TTP formulation containing retinol, retinyl acetate, and retinyl palmitate for 24 weeks
Number of subjects: 24
Study 35675051 — intervention group
Group type: COMPARATOR
Intervention: 0.02% RA for 24 weeks
Number of subjects: 24
Study 35675051 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1% TTP formulation
Number of subjects: 24
Study 32086591 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified agar plate fecal culture (mAPC)
Number of subjects: 1076
Study 32086591 — intervention group
Group type: COMPARATOR
Intervention: Standard agar plate culture (sAPC)
Number of subjects: 1076
Study 35805277 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Volume Training (HVT)
Number of subjects: 28
Study 35805277 — intervention group
Group type: COMPARATOR
Intervention: Standard Training Program (Control)
Number of subjects: 28
Study 32971155 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimum diabetes care including Ramadan-focused education, flash glucose monitoring, dietary advice, and treatment adjustment
Number of subjects: 30
Study 35380268 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory dietary intervention (six monthly food-preparation workshops and twelve motivational interviewing telephone calls)
Number of subjects: 153
Study 35380268 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 153
Study 33663549 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization (EMD) group (n = 55)
Number of subjects: 110
Study 33663549 — intervention group
Group type: COMPARATOR
Intervention: Retrieval‐only control group (n = 55)
Number of subjects: 110
Study 32673517 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (20 mg)
Number of subjects: 18
Study 32673517 — intervention group
Group type: COMPARATOR
Intervention: Abdominal compression (40 mm Hg)
Number of subjects: 18
Study 32673517 — intervention group
Group type: COMPARATOR
Intervention: Combination of abdominal compression and propranolol
Number of subjects: 18
Study 35653554 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofol (0.4 mg/kg)
Number of subjects: 289
Study 35653554 — intervention group
Group type: COMPARATOR
Intervention: Propofol (1.5 mg/kg)
Number of subjects: 289
Study 35653554 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofol
Number of subjects: 289
Study 35653554 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 289
Study 32727729 — intervention group
Group type: EXPERIMENTAL
Intervention: Subretinal transplantation of hESC-derived retinal pigment epithelium (RPE) cells
Number of subjects: 3
Study 32651595 — intervention group
Group type: EXPERIMENTAL
Intervention: 140-kV orthovoltage X-rays
Number of subjects: 22
Study 32651595 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-MV linear accelerator (linac)
Number of subjects: 22
Study 34297275 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention
Number of subjects: 50
Study 34297275 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control
Number of subjects: 50
Study 35486510 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetric N-Ceram Bulk Fill (TBF)
Number of subjects: 80
Study 35486510 — intervention group
Group type: COMPARATOR
Intervention: Tetric-Ceram HB (TBF/V)
Number of subjects: 80
Study 35739534 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (N=44)
Number of subjects: 59
Study 35739534 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=15)
Number of subjects: 59
Study 32787506 — intervention group
Group type: EXPERIMENTAL
Intervention: FIND intervention (web conferencing to facilitate family participation in care plan meetings)
Number of subjects: 0
Study 32787506 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 36249062 — intervention group
Group type: EXPERIMENTAL
Intervention: Irreversible electroporation (IRE)
Number of subjects: 152
Study 36249062 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 152
Study 33181232 — intervention group
Group type: EXPERIMENTAL
Intervention: Bougie-assisted ETI
Number of subjects: 1227
Study 33181232 — intervention group
Group type: COMPARATOR
Intervention: Non-Bougie ETI
Number of subjects: 1227
Study 33583009 — intervention group
Group type: EXPERIMENTAL
Intervention: Methicillin-sensitive Staphylococcus aureus (MSSA) identified in 21 patients (41.17%).
Number of subjects: 51
Study 33583009 — intervention group
Group type: EXPERIMENTAL
Intervention: Escherichia coli and Staphylococcus epidermidis each found in 4 patients (7.84%).
Number of subjects: 51
Study 33583009 — intervention group
Group type: EXPERIMENTAL
Intervention: Methicillin-resistant Staphylococcus aureus (MRSA) found in 3 patients (5.88%), all >65 years old.
Number of subjects: 51
Study 33583009 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality rate of 7.84% (n = 4), all patients were ≥67 years old, with 75% (3 of 4) being ≥75 years old.
Number of subjects: 51
Study 33583009 — intervention group
Group type: EXPERIMENTAL
Intervention: Rare infectious agents found in patients with IV drug abuse (Pseudomonas aeruginosa, Staphylococcus hominis, Citrobacter).
Number of subjects: 51
Study 34191552 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation therapy (VRT) plus modified Epley procedure for 4 weeks
Number of subjects: 47
Study 34191552 — intervention group
Group type: COMPARATOR
Intervention: Modified Epley procedure only
Number of subjects: 47
Study 32462607 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol
Number of subjects: 299
Study 32462607 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium
Number of subjects: 299